These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 8464186)
1. [Inhibitory activity of urinary macromolecule upon calcium oxalate crystal aggregation using an aggregometer]. Ebisuno S; Miyata K; Kohjimoto Y; Ohkawa T Nihon Hinyokika Gakkai Zasshi; 1993 Feb; 84(2):339-44. PubMed ID: 8464186 [TBL] [Abstract][Full Text] [Related]
2. Effect of urinary macromolecules on aggregation of calcium oxalate in recurrent calcium stone formers and healthy. Ebisuno S; Kohjimoto Y; Yoshida T; Ohkawa T Urol Res; 1993; 21(4):265-8. PubMed ID: 8212414 [TBL] [Abstract][Full Text] [Related]
3. Relationship between supersaturation and calcium oxalate crystallization in normals and idiopathic calcium oxalate stone formers. Borghi L; Guerra A; Meschi T; Briganti A; Schianchi T; Allegri F; Novarini A Kidney Int; 1999 Mar; 55(3):1041-50. PubMed ID: 10027942 [TBL] [Abstract][Full Text] [Related]
4. Urinary macromolecular substances as natural inhibitors of calcium oxalate crystal aggregation. Koide T; Takemoto M; Itatani H; Takaha M; Sonoda T Invest Urol; 1981 Mar; 18(5):382-6. PubMed ID: 6162821 [TBL] [Abstract][Full Text] [Related]
5. Effects of citrate on the different phases of calcium oxalate crystallization. Tiselius HG; Berg C; Fornander AM; Nilsson MA Scanning Microsc; 1993 Mar; 7(1):381-9; discussion 389-90. PubMed ID: 8316807 [TBL] [Abstract][Full Text] [Related]
6. [Inhibitory effect of CG-120 on the formation, growth and aggregation of calcium oxalate crystals in vitro]. Suzuki K; Tsugawa R Hinyokika Kiyo; 1988 Jun; 34(6):1073-6. PubMed ID: 3223452 [TBL] [Abstract][Full Text] [Related]
7. The effects of citrate and urine on calcium oxalate crystal aggregation. Tiselius HG; Fornander AM; Nilsson MA Urol Res; 1993; 21(5):363-6. PubMed ID: 8279094 [TBL] [Abstract][Full Text] [Related]
8. Calcium oxalate stone agglomeration reflects stone-forming activity: citrate inhibition depends on macromolecules larger than 30 kilodalton. Erwin DT; Kok DJ; Alam J; Vaughn J; Coker O; Carriere BT; Lindberg J; Husserl FE; Fuselier H; Cole FE Am J Kidney Dis; 1994 Dec; 24(6):893-900. PubMed ID: 7985666 [TBL] [Abstract][Full Text] [Related]
9. Strong inhibition of crystal-cell attachment by pediatric urinary macromolecules: a close relationship with high urinary citrate secretion. Miyake O; Kakimoto K; Tsujihata M; Yoshimura K; Takahara S; Okuyama A Urology; 2001 Sep; 58(3):493-7. PubMed ID: 11549512 [TBL] [Abstract][Full Text] [Related]
11. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein. Schwille PO; Schmiedl A; Manoharan M Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561 [TBL] [Abstract][Full Text] [Related]
12. Citric acid or citrates in urine: which should we focus on in the prevention of calcium oxalate crystals and stones? Laube N; Jansen B; Hesse A Urol Res; 2002 Oct; 30(5):336-41. PubMed ID: 12389124 [TBL] [Abstract][Full Text] [Related]
13. Crystalline aggregation in vitro: interaction between urinary macromolecules and the micromolecular environment. Guerra A; Meschi T; Schianchi T; Allegri F; Novarini A; Borghi L Acta Biomed; 2002; 73(1-2):11-26. PubMed ID: 12233273 [TBL] [Abstract][Full Text] [Related]
14. Uric acid-binding proteins in calcium oxalate stone formers and their effect on calcium oxalate crystallization. Kalaiselvi P; Udayapriya KL; Selvam R BJU Int; 1999 Jun; 83(9):919-23. PubMed ID: 10368229 [TBL] [Abstract][Full Text] [Related]
15. Effects of urinary macromolecules on the crystallization of calcium oxalate. Tiselius HG; Fornander AM; Nilsson MA Urol Res; 1990; 18(6):381-5. PubMed ID: 2100412 [TBL] [Abstract][Full Text] [Related]
16. Nucleation of calcium oxalate crystals by albumin: involvement in the prevention of stone formation. Cerini C; Geider S; Dussol B; Hennequin C; Daudon M; Veesler S; Nitsche S; Boistelle R; Berthézène P; Dupuy P; Vazi A; Berland Y; Dagorn JC; Verdier JM Kidney Int; 1999 May; 55(5):1776-86. PubMed ID: 10231440 [TBL] [Abstract][Full Text] [Related]
17. [Uronic-acid-rich protein: a new glycoprotein inhibiting the crystallization of calcium oxalate in vitro]. Atmani F; Lacour B; Daudon M Nephrologie; 1996; 17(3):157-62. PubMed ID: 9064564 [TBL] [Abstract][Full Text] [Related]
18. Modulatory effect of the 23-kD calcium oxalate monohydrate binding protein on calcium oxalate stone formation during oxalate stress. Asokan D; Kalaiselvi P; Varalakshmi P Nephron Physiol; 2004; 97(1):p23-30. PubMed ID: 15153748 [TBL] [Abstract][Full Text] [Related]
19. Effects of urinary macromolecules on the nucleation of calcium oxalate in idiopathic stone formers and healthy controls. Borghi L; Meschi T; Guerra A; Bergamaschi E; Mutti A; Novarini A Clin Chim Acta; 1995 Jul; 239(1):1-11. PubMed ID: 7586581 [TBL] [Abstract][Full Text] [Related]
20. Risk factors for urinary calcium oxalate crystals as revealed by their specific enzymatic assay. Hallson PC; Rose GA Br J Urol; 1989 Nov; 64(5):451-7. PubMed ID: 2611612 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]